Publications by authors named "Alan Faull"

Claim this Profile
T
The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
John G Cumming, Justin F Bower, David Waterson, Alan Faull, Philip J Poyser

Bioorg Med Chem Lett· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis.
John G Cumming, Howard Tucker, John Oldfield, Colin Fielding, Adrian Highton, Alan Faull

Bioorg Med Chem Lett· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides.
John G Cumming, Simon J Brown, Anne E Cooper, Alan W Faull, Anthony P Flynn

Bioorg Med Chem Lett· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptor.
Jason G Kettle, Alan W Faull, Andy J Barker, D Huw Davies, Michael A Stone

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis